Leadership team
We are leaders in drug discovery, cancer biology, functional genomics and translational medicine pursuing the bold goal of tackling the genetic complexity of cancer. We are focused on drivers of cancer not targeted by current drugs as we seek to address a large unmet need for people with cancer.
Barbara Weber, MDPresident and Chief Executive Officer
Alan Huang, PhDChief Scientific Officer
Shakti Narayan, PhD, JDChief Business Officer
John Maxwell, PhDVP, Medicinal Chemistry
Daniella Beckman, CPAChief Financial Officer
Janid Ali, PhDVP, Biochemistry
Charles Davis, PhDSVP, Pharmaceutical Sciences
Dimitris Papoutsakis, PhDVP, Operations, Program and Portfolio Management
Tania PhilippVP, Human Resources
